Sara Vodopivec

Dr. Sara Vodopivec

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2025 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
SVSara Vodopivec
Sara Vodopivec
GKGorazd Kavšek
Gorazd Kavšek
PPPolona Pečlin
Polona Pečlin
MDMirjam Druškovič
Mirjam Druškovič
Objectives: The aim of our study was to assess the efficacy and safety of two different labor induction methods in patients after fetal demise beyond 28 weeks, with an unfavorable cervix: misoprostol—prostaglandin E1 analog (PGE1) and dinoprostone—prostaglandin E2 analog (PGE2). Methods: This retrospective single-center cohort study included all labor cases after fetal demise (intrauterine fetal death or termination of pregnancy with feticide) from 28 to 40 weeks of gestation, where labor was induced by either PGE1 or PGE2. The primary outcome was the induction-to-delivery time interval. Secondary outcomes included the proportion of patients who delivered within 24 h, the failed induction rate, the length of labor, pain during induction, the adverse outcome rate, and the post-labor hospital stay. Results: The induction-to-delivery time interval was shorter in the PGE1 group (p = 0.048). There was no statistically significant difference in the proportion of patients who delivered within 24 h (p = 0.651) and failed inductions (p = 0.18) between groups. The duration of labor was longer in the PGE2 group (p = 0.01). Oxytocin augmentation was more common in the PGE2 group (p < 0.001). Pain during induction was greater in women in the PGE1 group (p < 0.001). There were no statistically significant differences in adverse effects between groups. There was no significant difference in induction to delivery interval between the two methods when comparing lower and higher gestational ages (28 to 34 weeks, p = 0.18; 35 to 40 weeks, p = 0.343). Conclusions: Our findings support the use of a PGE1 regimen for third-trimester labor induction after fetal demise, when no contraindications exist. This approach appears to improve the efficiency of induction and may enhance overall patient care by reducing intervention needs.

27 October 2025 in Slovenian Medical Journal
Verified
Journal Article
Open access
PDF file
SVSara Vodopivec
Sara Vodopivec
DŠDarija Šćepanović
Darija Šćepanović
MBMija Blaganje
Mija Blaganje
Ob prvem vaginalnem porodu ženske pride v 10–35 % do avulzije oz. odtrganja dela mišice levator ani (MLA) z njenega narastišča na sramni kosti. Avulzija MLA je pomemben dejavnik tveganja za motnje v delovanju medeničnega dna in za zdrs medeničnih organov. MLA sestavljajo 3 strukturne komponente: m. iliococcygeus, m. pubococcygeus, m. puborectalis. Slednja tvori zanko okrog anorektalnega stika in s tem vzdržuje anorektalni kot. Trikotni prostor, ki ga zanka MLA obdaja, imenujemo levatorjev hiatus, skozi katerega potekajo sečnica, nožnica in anus. Levatorjev hiatus predstavlja največjo potencialno herniacijsko odprtino v telesu. Ob kronanju plodove glavice se morajo medialne vitre MLA raztegniti tudi do trikratne dolžine v mirovanju. Doslej dokazani dejavniki tveganja za avulzijo MLA so: višja starost ob prvem porodu, nižji indeks telesne mase porodnice, porod s forcepsom in z vakuumsko ekstrakcijo, podaljšana druga porodna doba. O vlogi epiziotomije se literatura razhaja. Epiduralna analgezija bi lahko bila zaščitni dejavnik. Klinično lahko avulzijo MLA prepoznamo s palpacijo kontinuitete mišice preko stene nožnice. Diagnostični standard za avulzijo MLA je transperinealni ultrazvočni pregled (UZ). Zgodnje odkrivanje in ukrepanje bi bilo smiselno, da bi izboljšali oskrbo žensk s porodno poškodbo MLA in zmanjšali vpliv le-te na kakovost življenja ženske. Pomembno bi bilo, da bi imele ženske s porodno poškodbo medeničnega dna možnost fizioterapevtske obravnave po porodu. Transperinealni UZ za oceno MLA in analnega sfinktra bi bilo smiselno opraviti pri ženskah po prvem vaginalnem porodu, predvsem v primeru večje poškodbe porodne poti po porodu in v primeru poteka poroda z večjim tveganjem za porodno poškodbo MLA.